Mandate

Vinge advises Lantmännen in connection with its acquisition of the remaining shares in Scandbio

Vinge has advised Lantmännen in connection with its acquisition of the remaining shares in Scandbio AB. Scandbio AB was founded in 2014 when Lantmännen merged its operations with the Finnish company Neova. Both owners have held an equal number of shares in the 50/50 joint venture company since 2014.

Scandbio is Sweden’s largest company in the fixed refined forestry fuel sector with an annual turnover of around MSEK 1 000. The company is headquartered in Jönköping with operations at five sites in Sweden and one in Latvia. Scandbio manufactures, markets and sells wood pellets fuel to Sweden, Denmark and the Baltic States as well as stable pellets for the Swedish market. The company provides both industrial facilities as well as municipal and state-owned operations, local entrepreneurs and individual home owners with 100 per cent renewable energy.

The transaction is subject to the requisite approvals by the competition authorities.

Vinge’s team consisted of Christina Kokko and Elsie Nassar (M&A) together with Marcus Glader, Johan Wahlbom and Jesper Ekman (Merger filing).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026